Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cholangiocarcinoma; Liver”

327 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 327 results

Not applicableLooking for participantsNCT07224750
What this trial is testing

A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer

Who this might be right for
Hepatocellular Carcinoma (HCC)CholangiocarcinomaPancreatic Ductal Adenocarcinoma (PDAC)+3 more
City of Hope Medical Center 1,000
Not applicableStudy completedNCT03644173
What this trial is testing

Personal Resilience Empowerment Program Study

Who this might be right for
Lung CancerCholangiocarcinomaPancreatic Cancer+1 more
Hackensack Meridian Health 37
Early research (Phase 1)Looking for participantsNCT07106827
What this trial is testing

GV20-0251 in Advanced or Refractory Solid Tumors

Who this might be right for
HCC - Hepatocellular CarcinomaCholangiocarcinomaMelanoma+5 more
West China Hospital 10
Testing effectiveness (Phase 2)Study completedNCT03579771
What this trial is testing

Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer

Who this might be right for
Resectable CholangiocarcinomaStage IB Intrahepatic Cholangiocarcinoma AJCC v8Stage II Intrahepatic Cholangiocarcinoma AJCC v8+3 more
Emory University 30
Testing effectiveness (Phase 2)Study completedNCT03111732
What this trial is testing

Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)

Who this might be right for
Biliary Tract NeoplasmsCholangiocarcinomaBile Duct Cancer+2 more
National Cancer Institute (NCI) 11
Not applicableActive Not RecruitingNCT06707025
What this trial is testing

The Expression of CD24 "do-not-eat-me" Signal in Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Hadassah Medical Organization 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT06999512
What this trial is testing

Impact of Comprehensive Geriatric Management on Morbidity and Quality of Life in Elderly Patients Undergoing Major Hepatectomy and Pancreaticoduodenectomy for Cancer

Who this might be right for
Hepatobiliary CancerPancreatic Cancer
Assistance Publique - Hôpitaux de Paris 526
Testing effectiveness (Phase 2)Looking for participantsNCT07105748
What this trial is testing

HAIC Combined With Camrelizumab Plus Rivoceranib for Advanced Mixed Hepatocellular-cholangiocarcinoma (HCC-CCA)

Who this might be right for
Mixed Hepatocellular-cholangiocarcinoma
Fudan University 45
Not applicableLooking for participantsNCT06260943
What this trial is testing

Targeted Navigation in Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular CarcinomaCholangiocarcinomaHepatobiliary Cancer
University of Miami 210
Not applicableLooking for participantsNCT07263217
What this trial is testing

Mechanistic Study on the Protective and Regenerative Effects of Spirulina in Hepatectomy-Related Liver Injury

Who this might be right for
Cholangiocarcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 30
Testing effectiveness (Phase 2)Looking for participantsNCT05265208
What this trial is testing

Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver Cancer

Who this might be right for
Resectable Intrahepatic Cholangiocarcinoma
Center Eugene Marquis 62
Not applicableNot Yet RecruitingNCT07768085
What this trial is testing

Pragmatic RCT of AI-Assisted Reading for Malignant Hepatic Lesions on CE-CT

Who this might be right for
Hepatocellular Carcinoma (HCC)Intrahepatic Cholangiocarcinoma (Icc)Hepatic Metastasis+3 more
Shengjing Hospital 40,000
Not applicableWithdrawnNCT01875549
What this trial is testing

Comparison Between Unilateral Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction to Use a LCD Stent

Who this might be right for
Obstruction of Biliary TreeCholangiocarcinomaHepatocellular Carcinoma+2 more
Kwang Hyuck Lee
Not applicableLooking for participantsNCT06541652
What this trial is testing

A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers

Who this might be right for
HepatocholangiocarcinomaFibrolamellar CarcinomaHepatic Epithelioid Hemangioendothelioma+7 more
Federation Francophone de Cancerologie Digestive 150
Not applicableUnknownNCT04386772
What this trial is testing

Portal Vein Embolization Using Coils Plus TAGM vs Multiple Coils for Patients With Perihilar Cholangiocarcinoma or Hepatocellular Carcinoma

Who this might be right for
Portal Vein OcclusionCholangiocarcinoma, PerihilarHepatocellular Carcinoma+1 more
Eastern Hepatobiliary Surgery Hospital 56
Testing effectiveness (Phase 2)Study completedNCT03895970
What this trial is testing

Lenvatinib Combined Pembrolizumab in Advanced Hepatobiliary Tumors

Who this might be right for
Liver Neoplasm Malignant PrimaryCholangiocarcinomaCombinational Immunotherapy+1 more
Peking Union Medical College Hospital 32
Not applicableLooking for participantsNCT07717437
What this trial is testing

DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.

Who this might be right for
Liver CancerLiver Metastases
Maastricht University Medical Center 350
Testing effectiveness (Phase 2)Study completedNCT02821754
What this trial is testing

A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)

Who this might be right for
Biliary Tract NeoplasmsLiver CancerHepatocellular Carcinoma+2 more
National Cancer Institute (NCI) 54
Not applicableUnknownNCT05718349
What this trial is testing

FGF19 in Obstructive Cholestasis: "Unveil the Signal"

Who this might be right for
CholestasisIcterusCholangiocarcinoma+2 more
Nicole Hildebrand 81
Not applicableStudy completedNCT07225452
What this trial is testing

An Exosomal miRNA-based Liquid Biopsy for ICC Detection

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
City of Hope Medical Center 535
Next Page